JP Morgan Chase
SRTA

JP Morgan Chase’s Strata Critical Medical Inc SRTA Stock Holding History

JP Morgan Chase’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13,300
Closed -$117K – 6601
2021
Q4 		$117K Hold
13,300
– – ﹤0.01% 5607
2021
Q3 		$138K Buy
+13,300
New +$116K ﹤0.01% 5411

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's SRTA Position: Q1 2026 in Review

JP Morgan Chase reduced its Strata Critical Medical Inc (SRTA) stake by 7.8% in Q1 2026, selling an estimated $130K and leaving 320,234 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #4424.

JP Morgan Chase first reported a position in SRTA in Q1 2020 and has held it in 21 quarters since. The position peaked at $3.19M in Q2 2024. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • JP Morgan Chase held 320,234 shares of Strata Critical Medical Inc worth $1.3M as of Q1 2026.
  • JP Morgan Chase sold 26,928 Strata Critical Medical Inc shares in Q1 2026, an estimated $130K.
  • Strata Critical Medical Inc made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4424 holding.
  • JP Morgan Chase first reported a position in Strata Critical Medical Inc in Q1 2020 and has held it in 21 quarters since.
  • JP Morgan Chase's Strata Critical Medical Inc position peaked at $3.19M in Q2 2024.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.